Alpha-synuclein in Parkinson's disease and other synucleinopathies: from overt neurodegeneration back to early synaptic dysfunction.


Journal

Cell death & disease
ISSN: 2041-4889
Titre abrégé: Cell Death Dis
Pays: England
ID NLM: 101524092

Informations de publication

Date de publication:
01 03 2023
Historique:
received: 19 10 2022
accepted: 09 02 2023
revised: 18 01 2023
entrez: 1 3 2023
pubmed: 2 3 2023
medline: 4 3 2023
Statut: epublish

Résumé

Although the discovery of the critical role of α-synuclein (α-syn) in the pathogenesis of Parkinson's disease (PD) is now twenty-five years old, it still represents a milestone in PD research. Abnormal forms of α-syn trigger selective and progressive neuronal death through mitochondrial impairment, lysosomal dysfunction, and alteration of calcium homeostasis not only in PD but also in other α-syn-related neurodegenerative disorders such as dementia with Lewy bodies, multiple system atrophy, pure autonomic failure, and REM sleep behavior disorder. Furthermore, α-syn-dependent early synaptic and plastic alterations and the underlying mechanisms preceding overt neurodegeneration have attracted great interest. In particular, the presence of early inflammation in experimental models and PD patients, occurring before deposition and spreading of α-syn, suggests a mechanistic link between inflammation and synaptic dysfunction. The knowledge of these early mechanisms is of seminal importance to support the research on reliable biomarkers to precociously identify the disease and possible disease-modifying therapies targeting α-syn. In this review, we will discuss these critical issues, providing a state of the art of the role of this protein in early PD and other synucleinopathies.

Identifiants

pubmed: 36859484
doi: 10.1038/s41419-023-05672-9
pii: 10.1038/s41419-023-05672-9
pmc: PMC9977911
doi:

Substances chimiques

alpha-Synuclein 0

Types de publication

Journal Article Review Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

176

Informations de copyright

© 2023. The Author(s).

Références

J Neuropathol Exp Neurol. 2018 Jul 1;77(7):598-607
pubmed: 29850876
Ann Neurol. 2019 Oct;86(4):593-606
pubmed: 31343083
J Neurosci. 2000 May 1;20(9):3214-20
pubmed: 10777786
Neurology. 2017 Jul 4;89(1):88-100
pubmed: 28592453
Science. 1997 Jun 27;276(5321):2045-7
pubmed: 9197268
Nat Neurosci. 2014 Aug;17(8):1022-30
pubmed: 25065439
Mov Disord. 2020 Nov;35(11):1957-1965
pubmed: 32882100
NPJ Parkinsons Dis. 2022 Nov 24;8(1):162
pubmed: 36424392
Mov Disord. 2019 Nov;34(11):1739-1744
pubmed: 31571286
Lancet Neurol. 2020 Jul;19(7):591-600
pubmed: 32562684
Proc Natl Acad Sci U S A. 2011 Mar 8;108(10):4194-9
pubmed: 21325059
Proc Natl Acad Sci U S A. 2013 Oct 15;110(42):E4016-25
pubmed: 24082145
Acta Neuropathol. 2013 Jun;125(6):795-813
pubmed: 23604588
Mov Disord. 2019 Oct;34(10):1406-1422
pubmed: 31483900
Nat Commun. 2018 Feb 19;9(1):712
pubmed: 29459792
Biochem Biophys Res Commun. 2007 Mar 16;354(3):707-11
pubmed: 17254549
Nat Rev Neurosci. 2013 Jun;14(6):383-400
pubmed: 23686171
Annu Rev Neurosci. 2011;34:441-66
pubmed: 21469956
J Neurosci. 2012 Sep 26;32(39):13454-69
pubmed: 23015436
Lancet Neurol. 2009 Apr;8(4):382-97
pubmed: 19296921
Cold Spring Harb Perspect Med. 2018 Mar 1;8(3):
pubmed: 28108534
Front Mol Neurosci. 2014 May 13;7:42
pubmed: 24860424
Neurobiol Dis. 2017 Sep;105:321-327
pubmed: 27956085
Proc Natl Acad Sci U S A. 2021 Mar 9;118(10):
pubmed: 33649211
Nat Genet. 2010 Sep;42(9):781-5
pubmed: 20711177
Biochim Biophys Acta. 2009 Nov;1787(11):1334-41
pubmed: 19481532
Nat Rev Neurosci. 2017 Jan 20;18(2):101-113
pubmed: 28104909
J Mol Biol. 2009 Jun 5;389(2):413-24
pubmed: 19285989
Brain. 2021 Dec 16;144(11):3477-3491
pubmed: 34297092
Mol Neurodegener. 2018 Feb 22;13(1):9
pubmed: 29467003
Parkinsonism Relat Disord. 2005 Dec;11(8):493-8
pubmed: 16154792
Ann Neurol. 2014 Mar;75(3):351-62
pubmed: 24243558
Neuroreport. 2007 Oct 8;18(15):1543-6
pubmed: 17885598
Ann Neurol. 2005 Dec;58(6):963-7
pubmed: 16240369
Mov Disord. 2019 Jan;34(1):41-44
pubmed: 30484897
Trends Neurosci. 2000 Mar;23(3):120-6
pubmed: 10675916
Front Aging Neurosci. 2021 Jul 08;13:702639
pubmed: 34305577
Cell. 2010 Mar 19;140(6):918-34
pubmed: 20303880
Neuron. 2012 Jul 12;75(1):58-64
pubmed: 22794260
J Neurol Neurosurg Psychiatry. 2018 Apr;89(4):339-345
pubmed: 29248892
Front Neurosci. 2018 Feb 19;12:80
pubmed: 29515354
Brain. 2013 Aug;136(Pt 8):2419-31
pubmed: 23884810
Mov Disord. 2021 Sep;36(9):2057-2065
pubmed: 33899255
Mol Biol Cell. 2014 Dec 15;25(25):4010-23
pubmed: 25298402
Front Neurosci. 2020 Mar 31;14:286
pubmed: 32296304
J Biol Chem. 2001 Jun 22;276(25):22680-4
pubmed: 11312271
J Neurosci. 2006 Nov 15;26(46):11915-22
pubmed: 17108165
Sci Rep. 2018 Nov 1;8(1):16165
pubmed: 30385782
J Exp Med. 2012 May 7;209(5):975-86
pubmed: 22508839
J Biol Chem. 2015 Dec 4;290(49):29542-54
pubmed: 26442590
Neurology. 2012 Dec 11;79(24):2307-14
pubmed: 23152586
Cell Mol Neurobiol. 2017 Oct;37(7):1217-1226
pubmed: 28028735
Mov Disord. 2012 Oct;27(12):1478-83
pubmed: 23008164
Mov Disord. 2022 Oct;37(10):2045-2056
pubmed: 35959805
Science. 2016 May 6;352(6286):712-716
pubmed: 27033548
Neurology. 2008 Mar 25;70(13):1042-8
pubmed: 18362284
Neurobiol Dis. 2018 Jan;109(Pt B):249-257
pubmed: 28400134
Nature. 1997 Aug 28;388(6645):839-40
pubmed: 9278044
Science. 2000 Feb 18;287(5456):1265-9
pubmed: 10678833
J Neurosci. 2011 May 11;31(19):7111-21
pubmed: 21562273
Brain. 2010 Jul;133(Pt 7):2032-44
pubmed: 20534649
Neuron. 2000 Jan;25(1):239-52
pubmed: 10707987
Nat Commun. 2018 Feb 5;9(1):504
pubmed: 29402935
Clin Auton Res. 2021 Dec;31(6):677-684
pubmed: 34669076
Brain. 2022 Sep 14;145(9):3058-3071
pubmed: 35722765
Nat Commun. 2020 Feb 18;11(1):934
pubmed: 32071315
J Neurosci. 2016 Oct 12;36(41):10510-10521
pubmed: 27733604
Mov Disord. 2019 Apr;34(4):536-544
pubmed: 30840785
Brain. 2019 May 1;142(5):1365-1385
pubmed: 30927362
J Clin Invest. 2009 Jan;119(1):182-92
pubmed: 19104149
Brain Res. 2011 Mar 25;1382:37-44
pubmed: 21276428
Neuropathol Appl Neurobiol. 2022 Dec;48(7):e12844
pubmed: 35906771
Brain. 1991 Oct;114 ( Pt 5):2283-301
pubmed: 1933245
Mov Disord. 2015 Oct;30(12):1591-601
pubmed: 26474316
Acta Neuropathol. 2019 May;137(5):825-836
pubmed: 30805666
J Parkinsons Dis. 2021;11(3):1079-1089
pubmed: 34092654
Brain. 2011 Nov;134(Pt 11):3290-8
pubmed: 22075521
J Neuroimmune Pharmacol. 2012 Dec;7(4):927-38
pubmed: 23054369
J Physiol. 1993 Jul;466:727-47
pubmed: 8410714
Nat Rev Neurol. 2017 Apr;13(4):232-243
pubmed: 28303913
Nature. 2017 Jun 29;546(7660):656-661
pubmed: 28636593
Brain. 2005 Nov;128(Pt 11):2665-74
pubmed: 16219675
Neurobiol Dis. 2012 Mar;45(3):939-53
pubmed: 22182688
Science. 2010 Sep 24;329(5999):1663-7
pubmed: 20798282
Int J Mol Sci. 2020 Nov 10;21(22):
pubmed: 33182554
Neuroimage. 2019 Apr 15;190:69-78
pubmed: 29277406
J Neurosci. 2014 Jul 9;34(28):9364-76
pubmed: 25009269
Biochim Biophys Acta. 2014 Jun;1840(6):2014-24
pubmed: 24561157
Nat Commun. 2014 May 29;5:3827
pubmed: 24871041
N Engl J Med. 2022 Aug 4;387(5):408-420
pubmed: 35921450
Proc Natl Acad Sci U S A. 2019 Jun 4;116(23):11113-11115
pubmed: 31110017
Trends Neurosci. 2007 May;30(5):211-9
pubmed: 17367873
Brain. 1994 Apr;117 ( Pt 2):235-43
pubmed: 8186951
J Neurosci. 2004 Feb 25;24(8):1888-96
pubmed: 14985429
N Engl J Med. 2022 Aug 4;387(5):421-432
pubmed: 35921451
J Neurosci. 2009 Dec 9;29(49):15414-9
pubmed: 20007466
PLoS One. 2010 Jul 07;5(7):e11464
pubmed: 20628651
Cereb Cortex. 2017 Jan 1;27(1):400-410
pubmed: 26464477
Mov Disord. 2019 Aug;34(8):1154-1163
pubmed: 31211448
Nat Neurosci. 2019 Aug;22(8):1248-1257
pubmed: 31346295
J Comp Neurol. 2004 Nov 8;479(2):198-215
pubmed: 15452855
Front Aging Neurosci. 2014 Mar 31;6:53
pubmed: 24744728
Nature. 2011 Aug 14;477(7362):107-10
pubmed: 21841800
Nat Commun. 2018 Jun 12;9(1):2293
pubmed: 29895861
Mov Disord. 2015 Sep 15;30(11):1490-504
pubmed: 26371623
PLoS One. 2011 Apr 29;6(4):e19338
pubmed: 21559417
Nature. 2020 Feb;578(7794):273-277
pubmed: 32025029
J Neurosci. 1988 Aug;8(8):2804-15
pubmed: 3411354
Prog Brain Res. 2010;184:89-111
pubmed: 20887871
Brain. 2017 Jul 1;140(7):1959-1976
pubmed: 28549077
Biol Psychiatry. 2016 Mar 1;79(5):402-414
pubmed: 26392130
Acta Neuropathol. 2009 Jun;117(6):613-34
pubmed: 19399512
Neurobiol Dis. 2022 Jun 15;168:105698
pubmed: 35314318
Brain. 2012 Jul;135(Pt 7):2058-73
pubmed: 22719003
Cell Death Differ. 2005 Sep;12(9):1202-4
pubmed: 16094397
J Neurosci. 2009 Mar 18;29(11):3365-73
pubmed: 19295143
J Neurosci. 2014 Aug 6;34(32):10603-15
pubmed: 25100594
Nat Commun. 2020 Apr 20;11(1):1875
pubmed: 32313102
Glia. 2002 Nov;40(2):195-205
pubmed: 12379907
Proc Natl Acad Sci U S A. 2021 Mar 9;118(10):
pubmed: 33658371
J Biol Chem. 2002 Dec 13;277(50):48984-92
pubmed: 12351643
Front Cell Neurosci. 2018 Aug 06;12:247
pubmed: 30127724
Lancet Neurol. 2019 Jun;18(6):573-586
pubmed: 30981640
Science. 2017 Sep 22;357(6357):1255-1261
pubmed: 28882997
Arch Neurol. 2006 Apr;63(4):604-5
pubmed: 16606777
Trends Neurosci. 2007 Oct;30(10):545-53
pubmed: 17904652
Cell. 2012 Sep 14;150(6):1300, 1300.e1-2
pubmed: 22980986
Mov Disord. 2021 Nov;36(11):2508-2518
pubmed: 34002893
Neuron. 2010 Jul 29;67(2):294-307
pubmed: 20670836
Sci Rep. 2017 Jul 25;7(1):6363
pubmed: 28743955
Cell Immunol. 2018 May;327:77-82
pubmed: 29478949
Proc Natl Acad Sci U S A. 2012 Feb 28;109(9):3213-9
pubmed: 22315428
Sci Transl Med. 2016 Jun 8;8(342):342ra78
pubmed: 27280685
Neurobiol Dis. 2021 Feb;149:105229
pubmed: 33352233
Lancet Neurol. 2017 Oct;16(10):789-796
pubmed: 28684245

Auteurs

Paolo Calabresi (P)

Sezione di Neurologia, Dipartimento di Neuroscienze, Facoltà di Medicina e Chirurgia, Università Cattolica del Sacro Cuore, Rome, 00168, Italy. paolo.calabresi@policlinicogemelli.it.
Neurologia, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, 00168, Italy. paolo.calabresi@policlinicogemelli.it.

Alessandro Mechelli (A)

Dipartimento di Scienze Mediche e Chirurgiche, Istituto di Neurologia, Università "Magna Graecia", Catanzaro, Italy.

Giuseppina Natale (G)

Sezione di Neurologia, Dipartimento di Neuroscienze, Facoltà di Medicina e Chirurgia, Università Cattolica del Sacro Cuore, Rome, 00168, Italy.

Laura Volpicelli-Daley (L)

Center for Neurodegeneration and Experimental Therapeutics, University of Alabama at Birmingham, Birmingham, AL, 35294, USA.

Giulia Di Lazzaro (G)

Neurologia, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, 00168, Italy.

Veronica Ghiglieri (V)

Neurologia, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, 00168, Italy.
Università Telematica San Raffaele, Rome, 00166, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH